COVID-19 2022 update: transition of the pandemic to the endemic phase

M Biancolella, VL Colona, R Mehrian-Shai, JL Watt… - Human genomics, 2022 - Springer
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years.
Here, we review the current state of research into the disease with focus on its history …

[HTML][HTML] A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant

M Zhang, Y Liang, D Yu, B Du, W Cheng… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Vaccines are proving to be highly effective in controlling hospitalization and deaths
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

P Bastard, A Gervais, T Le Voyer, J Rosain… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1: 10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID …

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

T Nakanishi, S Pigazzini, F Degenhardt… - The Journal of …, 2021 - Am Soc Clin Investig
Background There is considerable variability in COVID-19 outcomes among younger adults,
and some of this variation may be due to genetic predisposition. Methods We combined …

Pre-existing autoantibodies neutralizing high concentrations of type I interferons in almost 10% of COVID-19 patients admitted to intensive care in Barcelona

X Solanich, R Rigo-Bonnin, VD Gumucio… - Journal of clinical …, 2021 - Springer
Background It is important to predict which patients infected by SARS-CoV-2 are at higher
risk of life-threatening COVID-19. Several studies suggest that neutralizing auto-antibodies …

Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19

X Solanich, G Vargas-Parra, CI Van der Made… - Frontiers in …, 2021 - frontiersin.org
Introduction Loss-of-function TLR7 variants have been recently reported in a small number
of males to underlie strong predisposition to severe COVID-19. We aimed to determine the …

COVID-19 annual update: a narrative review

M Biancolella, VL Colona, L Luzzatto, JL Watt… - Human genomics, 2023 - Springer
Three and a half years after the pandemic outbreak, now that WHO has formally declared
that the emergency is over, COVID-19 is still a significant global issue. Here, we focus on …

A focus on the spread of the delta variant of SARS-CoV-2 in India

G Novelli, VL Colona, PP Pandolfi - Indian Journal of Medical …, 2021 - journals.lww.com
538 INDIAN J MED RES, MAY & JUNE 2021 initial data show that this variant appears to
respond to currently available vaccines and is sensitive to antibodies generated by cured …

Development of antibody resistance in emerging mutant strains of SARS CoV‐2: impediment for COVID‐19 vaccines

NM Beeraka, OA Sukocheva, E Lukina… - Reviews in Medical …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory
syndrome coronavirus‐2 (SARS‐CoV‐2), a highly infectious agent associated with …

Update on human genetic susceptibility to COVID-19: susceptibility to virus and response

VL Colona, V Vasiliou, J Watt, G Novelli… - Human genomics, 2021 - Springer
Update on human genetic susceptibility to COVID-19: susceptibility to virus and response |
Human Genomics Skip to main content SpringerLink Account Menu Find a journal Publish with …